Y. Cavusoglu Et Al. , "COST-EFFECTIVENESS OF USING DAPAGLIFLOZIN IN THE TREATMENT OF HEART FAILURE WITH REDUCED EJECTION FRACTION: A PHARMACOECONOMIC MODEL ANALYSIS," VALUE IN HEALTH , vol.25, no.1, 2022
Cavusoglu, Y. Et Al. 2022. COST-EFFECTIVENESS OF USING DAPAGLIFLOZIN IN THE TREATMENT OF HEART FAILURE WITH REDUCED EJECTION FRACTION: A PHARMACOECONOMIC MODEL ANALYSIS. VALUE IN HEALTH , vol.25, no.1 .
Cavusoglu, Y., Demir, O., Dinc, M., Ozsoy, A., Erdogan, A., & Ozer, S., (2022). COST-EFFECTIVENESS OF USING DAPAGLIFLOZIN IN THE TREATMENT OF HEART FAILURE WITH REDUCED EJECTION FRACTION: A PHARMACOECONOMIC MODEL ANALYSIS. VALUE IN HEALTH , vol.25, no.1.
Cavusoglu, Y. Et Al. "COST-EFFECTIVENESS OF USING DAPAGLIFLOZIN IN THE TREATMENT OF HEART FAILURE WITH REDUCED EJECTION FRACTION: A PHARMACOECONOMIC MODEL ANALYSIS," VALUE IN HEALTH , vol.25, no.1, 2022
Cavusoglu, Y. Et Al. "COST-EFFECTIVENESS OF USING DAPAGLIFLOZIN IN THE TREATMENT OF HEART FAILURE WITH REDUCED EJECTION FRACTION: A PHARMACOECONOMIC MODEL ANALYSIS." VALUE IN HEALTH , vol.25, no.1, 2022
Cavusoglu, Y. Et Al. (2022) . "COST-EFFECTIVENESS OF USING DAPAGLIFLOZIN IN THE TREATMENT OF HEART FAILURE WITH REDUCED EJECTION FRACTION: A PHARMACOECONOMIC MODEL ANALYSIS." VALUE IN HEALTH , vol.25, no.1.
@article{article, author={Y. Cavusoglu Et Al. }, title={COST-EFFECTIVENESS OF USING DAPAGLIFLOZIN IN THE TREATMENT OF HEART FAILURE WITH REDUCED EJECTION FRACTION: A PHARMACOECONOMIC MODEL ANALYSIS}, journal={VALUE IN HEALTH}, year=2022}